© 2022 WRVO Public Media
bg.jpg
Your Source for NPR News
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

This week: Ovarian cancer, diabetes drug development, graft-versus-host disease

Gynecologic oncology researchers are testing a surgery that may help women who have a high genetic risk for developing ovarian cancer. They want to know whether preemptively removing the fallopian tubes -- and leaving the ovaries intact -- can reduce a woman's risk of ovarian cancer. Explaining the study in this week's “HealthLink on Air” is Dr. Rinki Agarwal, an associate professor of obstetrics and gynecology at Upstate and also the medical director of the Upstate Cancer Center's gynecologic oncology program and its genetics program.

Also in this episode, Syracuse University chemistry professor Robert Doyle tells about developing a diabetes drug without side effects. And, physician-scientist Mobin Karimi explains his work on a rare condition called graft-versus-host disease, which can threaten people who undergo transplants.

Listen to Healthlink on Air every Sunday at 6 a.m. on WRVO.